Make Your Medical Device Pitch for Kids! ™ – Joint NCC-PDI + CTIP Edition

Under this solicitation, two FDA-funded Pediatric Device Consortia grant programs, CTIP and NCC-PDI, have come together to maximize their resources to select and support a new cohort of device innovators to receive grant funding and wraparound services by the two consortia. We are seeking proposals from inventors from all sectors – including the business community and academic medical centers – who are proposing a medical device solution to address a significant unmet need in the pediatric population.

Proposals should be directed towards the development of a commercializable product, and not research of a scientific concept. Issues such as prototyping, manufacturing, marketing, and regulatory clearance will be paramount and should be addressed explicitly.

Read More

IllumiCare App Recommends Trials as Therapeutic Option, New Data Capture Interface Increases Real-World Patient Compliance, More

December 27, 2022 | A 16-gene molecular signature investigation based on gene expression differences between patients with and without local recurrence after breast-conserving surgery; analytically sensitive infectious disease panels to support laboratory research; eClinical solutions to make clinical

Read More

National Capital Consortium for Pediatric Device InnovationRequest for Proposals

Funded by the Food and Drug Administration (FDA), the National Capital Consortium for Pediatric Device Innovation (NCC-PDI) solicits proposals from medical device companies with FDA-cleared or approved medical devices that may address an unmet need in the pediatric population, and therefore seeking pediatric market clearance in the US. If chosen, the partnering team will provide technical expertise where needed and include (1) access to mentors, (2) design study protocol implementing RWE methodologies, (3) facilitate IRB submission, (4) facilitate study implementation, (5) furnish cloud services and data science support, and (6) provide regulatory, reimbursement, and supply chain consultation. The partnering team will facilitate meetings with the device sponsors and FDA.

The pediatric population (neonates, infants, children, and adolescents) includes patients who are 21 years of age or younger at the time of diagnosis or treatment.

Read More